Selank belongs to a small group of regulatory peptides developed from endogenous immune fragments and modified for stability. It is studied primarily in neuropeptide and neuroimmune research.

What Is Selank?

Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring tetrapeptide (Thr-Lys-Pro-Arg) released from the heavy chain of immunoglobulin G. Tuftsin has well-documented immunomodulatory activity but is degraded very rapidly, which limits its usefulness experimentally.

Selank addresses this by appending a Pro-Gly-Pro tripeptide to the tuftsin sequence. That extension substantially increases resistance to enzymatic degradation while preserving the parent activity — a general stabilisation strategy also used in Semax, which appends the same Pro-Gly-Pro motif to an ACTH fragment.

How Researchers Understand Its Mechanism

No single receptor has been established as the primary target, and the literature describes several parallel observations rather than one unified pathway.

The most cited concerns GABAergic signaling. Studies have reported changes in the expression of GABA-A receptor subunits in rodent brain tissue following exposure, which is the basis for its classification as an anxiolytic research compound. A second strand concerns brain-derived neurotrophic factor, where exposure has been associated with altered BDNF expression in hippocampal tissue — an effect shared with Semax.

A third concerns monoamine turnover, with reported effects on serotonin metabolism, and a fourth retains the immunological character of the parent peptide, with reported changes in interleukin expression. This last point is what makes Selank interesting as a neuroimmune tool: it sits at the intersection of both systems.

Much of this literature originates from a relatively small number of research groups, which is worth weighing when assessing the evidence.

Areas of Scientific Investigation

Research applications include anxiolytic peptide models, GABAergic and serotonergic signaling studies, BDNF expression research, neuroimmune interaction models, and comparative work against Semax examining whether the shared Pro-Gly-Pro extension confers similar stability characteristics.

Selank and Semax

The two are frequently studied together because they share a design principle but derive from different parents — Selank from an immune peptide, Semax from ACTH(4-10). Comparing them allows researchers to ask how much of the observed activity comes from the parent sequence versus the stabilising extension.

Why Purity and Verification Matter

Reproducibility in peptide research depends on knowing exactly what is in the vial. Sequence-related impurities, truncated fragments and residual synthesis reagents can all influence experimental outcomes, and two preparations nominally of the same compound can behave differently if purity differs. Independent HPLC and mass spectrometry testing establishes both identity and purity, which is why third-party verification is standard practice for research-grade material. All compounds referenced here are supplied as lyophilized powder at greater than 98 percent purity with independent verification.

Summary

Selank is a stabilised heptapeptide analog of the immune fragment tuftsin, studied for effects on GABAergic signaling, BDNF expression, monoamine turnover and cytokine expression. Its mechanism is not resolved to a single receptor. It is intended strictly for laboratory research.

Related Research Peptides

Selank 10mg · Semax 10mg · Pinealon 10mg · Oxytocin 2mg · VIP 5mg

For laboratory and research use only. Not for human or veterinary use, and not for diagnostic or therapeutic purposes.